Genstar Capital is a private equity firm that seeks investments in life science, healthcare, medical products, industrial technology, software, financial services, packaging, building materials, manufacturing, and business services companies. Genstar looks to invest between $50 and $400 million of equity capital in businesses valued up to $1 billion. Target transaction situations include control-oriented leveraged buyouts of corporate divisions, privately held businesses or public companies, minority investments in privately held businesses or public companies, ownership restructurings/recapitalizations of privately held businesses, growth equity financings, partnerships with other strategic or financial buyers, and take privates. Genstar Capital was formed in 1988 and is based in San Francisco, California.
Join Mergr to view the latest updates and news from San Francisco-based Genstar Capital.
In the last 3 years, Genstar Capital has acquired 6 companies. It has also invested in 1 other.
Genstar Capital’s most common sectors for investment are financial services (14%) and software (10%). The Firm’s most common investment types include secondary buyout (44%) and buyout (lbo, mbo, mbi) (32%). In total, Genstar Capital has invested in 20 US states and 5 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Catalent for $3.3B.
In the last 3 years, Genstar Capital has exited 10 companies. The Firm’s most common exit type is secondary buyout (38%). Genstar Capital’s largest (disclosed) exit occurred in 2018 when it sold Accruent for $2.0B.
Join Mergr to view Genstar Capital’s full profile and discover more mega-sized private equity firms just like it.
No obligation. Cancel anytime.